Afficher la couverture 'Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies. | Nash, Denis' en grand format
/5

0 avis

Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies.

Archive ouverte

Nash, Denis | Katyal, Monica | Brinkhof, Martin, W.G. | Keiser, Olivia | May, Margaret | Hughes, Rachael | Dabis, Francois | Wood, Robin | Sprinz, Eduardo | Schechter, Mauro | Egger, Matthias

Edité par CCSD ; Wolters Kluwer -

International audience. BACKGROUND: Few data are available on the long-term immunologic response to antiretroviral therapy (ART) in resource-limited settings, where ART is being rapidly scaled up using a public health approach, with a limited repertoire of drugs. OBJECTIVES: To describe immunologic response to ART among ART patients in a network of cohorts from sub-Saharan Africa, Latin America, and Asia. STUDY POPULATION/METHODS: Treatment-naive patients aged 15 and older from 27 treatment programs were eligible. Multilevel, linear mixed models were used to assess associations between predictor variables and CD4 cell count trajectories following ART initiation. RESULTS: Of 29 175 patients initiating ART, 8933 (31%) were excluded due to insufficient follow-up time and early lost to follow-up or death. The remaining 19 967 patients contributed 39 200 person-years on ART and 71 067 CD4 cell count measurements. The median baseline CD4 cell count was 114 cells/microl, with 35% having less than 100 cells/microl. Substantial intersite variation in baseline CD4 cell count was observed (range 61-181 cells/microl). Women had higher median baseline CD4 cell counts than men (121 vs. 104 cells/microl). The median CD4 cell count increased from 114 cells/microl at ART initiation to 230 [interquartile range (IQR) 144-338] at 6 months, 263 (IQR 175-376) at 1 year, 336 (IQR 224-472) at 2 years, 372 (IQR 242-537) at 3 years, 377 (IQR 221-561) at 4 years, and 395 (IQR 240-592) at 5 years. In multivariable models, baseline CD4 cell count was the most important determinant of subsequent CD4 cell count trajectories. CONCLUSION: These data demonstrate robust and sustained CD4 response to ART among patients remaining on therapy. Public health and programmatic interventions leading to earlier HIV diagnosis and initiation of ART could substantially improve patient outcomes in resource-limited settings.

Suggestions

Du même auteur

Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries.. Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries.: Tuberculosis on antiretroviral therapy

Archive ouverte | Brinkhof, Martin, W.G. | CCSD

International audience. We examined the incidence of and risk factors for tuberculosis during the first year of highly active antiretroviral therapy in low-income (4540 patients) and high-income (22,217 patients) co...

Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring.

Archive ouverte | Keiser, Olivia | CCSD

International audience. BACKGROUND: In high-income countries, viral load is routinely measured to detect failure of antiretroviral therapy (ART) and guide switching to second-line ART. Viral load monitoring is not g...

Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries.

Archive ouverte | Brinkhof, Martin, W.G. | CCSD

International audience. OBJECTIVE: To analyse the early loss of patients to antiretroviral therapy (ART) programmes in resource-limited settings. METHODS: Using data on 5491 adult patients starting ART (median age 3...

Chargement des enrichissements...